HealthCor Management’s Omeros OMER Stock Holding History

HealthCor Management’s Portfolio OMER Stock Details OMER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50,000	Closed	-$890K	–	95
2021 Q1	$890K	Buy	+50,000	New	+$972K	0.03%	79

Other funds holding OMER

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

HealthCor Management's OMER Position: Q2 2021 in Review

HealthCor Management sold out of Omeros (OMER) in Q2 2021, closing a stake of 50,000 shares — an estimated $890K sold.

HealthCor Management first reported a position in OMER in Q1 2021 and held it in 1 quarter. The position peaked at $890K in Q1 2021. 152 funds tracked by Wall St. Rank hold OMER as of Q2 2021.

HealthCor Management reported no remaining Omeros position as of Q2 2021 after selling out during the quarter.
HealthCor Management sold 50,000 Omeros shares in Q2 2021, an estimated $890K.
HealthCor Management first reported a position in Omeros in Q1 2021 and held it in 1 quarter.
HealthCor Management's Omeros position peaked at $890K in Q1 2021.
152 funds tracked by Wall St. Rank held Omeros as of Q2 2021.

Based on HealthCor Management's 13F filing for Q2 2021, filed 16 Aug 2021.